Q-501

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameQ-501
Drug Alias Name5Lo inhibitors (Qurient Therapeutics)asthma program (Qurient)Q-3Q-501
ClassificationSmall molecules
Mechanisms of ActionLeukotriene B4 receptor antagonistsArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenaseLeukotriene B4 receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQurient Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQurient Co Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A